Gβγ interacts with mTOR and promotes its activation

Evelyn Robles-Molina1, Misael Dionisio-Vicuña2, María Luisa Guzmán-Hernández1

  • 1Department of Pharmacology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (CINVESTAV-IPN), Apartado postal 14-740, México, D.F. 07360, Mexico.

Insights

G protein signaling involves Gβγ heterodimers directly interacting with mTOR (mechanistic Target of Rapamycin) to activate signaling pathways. This interaction promotes cell survival and polarization, highlighting new therapeutic targets.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • G protein-coupled receptors (GPCRs) utilize Gβγ heterodimers for cell polarization and survival.
  • Gβγ activation of PI3Kγ leads to AKT phosphorylation at Ser473, suggesting downstream activation of mTORC2.

Purpose of the Study:

  • To investigate the direct interaction between Gβγ and mTOR signaling pathways.
  • To determine if Gβγ directly contributes to mTOR complex activation.

Main Methods:

  • Co-immunoprecipitation assays to detect endogenous mTOR and Gβγ interaction.
  • In vitro binding assays using GST-fusion proteins of mTOR carboxyl-terminal regions with Gβγ heterodimers.
  • Analysis of substrate phosphorylation (p70S6K, AKT) under various conditions including rapamycin treatment and Gαi overexpression.

Main Results:

  • Endogenous mTOR was found to interact with Gβγ, modulated by serum stimulation.
  • The carboxyl-terminal region of mTOR, including the kinase domain, binds to Gβγ heterodimers (excluding Gβ4).
  • Both mTORC1 and mTORC2 complexes interact with Gβ₁γ₂, promoting phosphorylation of p70S6K and AKT, respectively. Rapamycin treatment and Gαi overexpression disrupted these interactions and downstream signaling.

Conclusions:

  • Gβγ directly interacts with and positively regulates both mTORC1 and mTORC2 signaling pathways.
  • These findings support targeting Gβγ signaling interfaces for therapeutic interventions.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K